BakerHostetler advises clients on developments in genetics, research design, big data analytics, mobile health technologies, and cloud computing, covering litigation against government agencies and competitors, patent portfolio management, and negotiations of mergers and development contracts. Stephanie Lodise co-leads the IP life sciences and advanced materials team from Philadelphia. Based in Denver, Winston Kirton co-leads the FDA practice, while in Washington, DC Timothy Worrall advises on domestic and international patent portfolios.
Legal 500 Editorial commentary

Key clients

  • Alevian, Inc.
  • Dragonfly Endoscopy
  • Outsourcing Facility Association
  • Nationwide Medical, Inc.
  • Johnson & Johnson
  • Xencor
  • FarmaKeio Outsourcing LLC and North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding

Work highlights

Represents the Outsourcing Facilities Association in multiple lawsuits against HHS and the FDA to challenge regulatory delays and decisions impacting drug compounding and shortage lists.
Represents several pharmacy compounders in litigation initiated by Eli Lilly & Co. and Novo Nordisk.
Provide sophisticated patent analysis, including patentability, freedom to operate, and patent application preparation for Alevian, and its lead candidate GDF-11 and therapeutic antibody strategy in treatment of stroke.
Practice head

Stephanie A. Lodise; Timothy A. Worrall; Winston S. Kirton